Literature DB >> 18971926

Hormonal regulation of hepatic drug-metabolizing enzyme activity during adolescence.

Mj Kennedy1.   

Abstract

Activities of drug-metabolizing enzymes (DMEs) are known to change throughout the course of physical and sexual maturation, with the greatest variability noted during infancy and adolescence. The mechanisms responsible for developmental regulation of DME are currently unknown. However, the hormonal changes associated with puberty/adolescence provide a theoretical framework for understanding the biochemical regulation of DME activity during growth and maturation. Important information regarding potential influences of growth and sex hormones can also be extrapolated from studies that evaluate changes in activities of DMEs occurring as a consequence of physiological, pathological, and/or pharmacological hormonal fluctuations. Collectively, current data support the hypothesis that isoform-specific alterations in DME activity during adolescence are mediated by sex and/or growth hormones. Characterization of the underlying biochemical alterations responsible for developmental changes in DME activity will require additional studies in which relationships between DMEs and important hormonal axes are evaluated during the course of pubertal development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18971926      PMCID: PMC2684751          DOI: 10.1038/clpt.2008.202

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  74 in total

Review 1.  Normal sexual maturation.

Authors:  P C Sizonenko
Journal:  Pediatrician       Date:  1987

2.  Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children.

Authors:  H Takahashi; S Ishikawa; S Nomoto; Y Nishigaki; F Ando; T Kashima; S Kimura; M Kanamori; H Echizen
Journal:  Clin Pharmacol Ther       Date:  2000-11       Impact factor: 6.875

Review 3.  Developmental pharmacology: a review of its application to clinical and basic science.

Authors:  J T Wilson
Journal:  Annu Rev Pharmacol       Date:  1972       Impact factor: 13.820

Review 4.  Pharmacogenetics in pediatrics. Implications for practice.

Authors:  J S Leeder; G L Kearns
Journal:  Pediatr Clin North Am       Date:  1997-02       Impact factor: 3.278

5.  No sex-related differences but significant inhibition by oral contraceptives of CYP2C19 activity as measured by the probe drugs mephenytoin and omeprazole in healthy Swedish white subjects.

Authors:  K Laine; G Tybring; L Bertilsson
Journal:  Clin Pharmacol Ther       Date:  2000-08       Impact factor: 6.875

6.  Hormonal effects on tirilazad clearance in women: assessment of the role of CYP3A.

Authors:  J C Fleishaker; L K Pearson; P G Pearson; L C Wienkers; N K Hopkins; G R Peters
Journal:  J Clin Pharmacol       Date:  1999-03       Impact factor: 3.126

7.  Growth hormone treatment increases cytochrome P450-mediated antipyrine clearance in man.

Authors:  N W Cheung; C Liddle; S Coverdale; J C Lou; S C Boyages
Journal:  J Clin Endocrinol Metab       Date:  1996-05       Impact factor: 5.958

8.  Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation.

Authors:  Sanna Palovaara; Olavi Pelkonen; Jouko Uusitalo; Stefan Lundgren; Kari Laine
Journal:  Clin Pharmacol Ther       Date:  2003-10       Impact factor: 6.875

Review 9.  Biologic and molecular mechanisms for sex differences in pharmacokinetics, pharmacodynamics, and pharmacogenetics: Part I.

Authors:  Marietta Anthony; Mary J Berg
Journal:  J Womens Health Gend Based Med       Date:  2002-09

10.  The effects of menopause and hormone replacement therapies on prednisolone and erythromycin pharmacokinetics.

Authors:  R Z Harris; S M Tsunoda; P Mroczkowski; H Wong; L Z Benet
Journal:  Clin Pharmacol Ther       Date:  1996-04       Impact factor: 6.875

View more
  22 in total

Review 1.  Clinical pharmacology in the adolescent oncology patient.

Authors:  Gareth J Veal; Christine M Hartford; Clinton F Stewart
Journal:  J Clin Oncol       Date:  2010-05-03       Impact factor: 44.544

2.  Pharmacovigilance for children's sake.

Authors:  Kristina Star; I Ralph Edwards
Journal:  Drug Saf       Date:  2014-02       Impact factor: 5.606

Review 3.  Clinical Pharmacokinetics and Pharmacodynamics of Antihyperglycemic Medications in Children and Adolescents with Type 2 Diabetes Mellitus.

Authors:  Fatemeh Akhlaghi; Kelly L Matson; Amir Hooshang Mohammadpour; Meghan Kelly; Asieh Karimani
Journal:  Clin Pharmacokinet       Date:  2017-06       Impact factor: 6.447

4.  Sex-related differences in hospital admissions attributed to adverse drug reactions in the Netherlands.

Authors:  Eline M Rodenburg; Bruno H Ch Stricker; Loes E Visser
Journal:  Br J Clin Pharmacol       Date:  2011-01       Impact factor: 4.335

5.  Bisphenol A-associated alterations in the expression and epigenetic regulation of genes encoding xenobiotic metabolizing enzymes in human fetal liver.

Authors:  Muna S Nahar; Jung H Kim; Maureen A Sartor; Dana C Dolinoy
Journal:  Environ Mol Mutagen       Date:  2013-11-09       Impact factor: 3.216

6.  In vitro hepatic metabolism explains higher clearance of voriconazole in children versus adults: role of CYP2C19 and flavin-containing monooxygenase 3.

Authors:  Souzan B Yanni; Pieter P Annaert; Patrick Augustijns; Joseph G Ibrahim; Daniel K Benjamin; Dhiren R Thakker
Journal:  Drug Metab Dispos       Date:  2010-01       Impact factor: 3.922

7.  Tacrolimus dose requirements in paediatric renal allograft recipients are characterized by a biphasic course determined by age and bone maturation.

Authors:  Noël Knops; Jean Herman; Maria van Dyck; Yasaman Ramazani; Edward Debbaut; Rita van Damme-Lombaerts; Elena Levtchenko; Lambertus P van den Heuvel; Steffen Fieuws; Dirk Kuypers
Journal:  Br J Clin Pharmacol       Date:  2016-12-13       Impact factor: 4.335

8.  Ontogeny and sorafenib metabolism.

Authors:  Eric I Zimmerman; Justin L Roberts; Lie Li; David Finkelstein; Alice Gibson; Amarjit S Chaudhry; Erin G Schuetz; Jeffrey E Rubnitz; Hiroto Inaba; Sharyn D Baker
Journal:  Clin Cancer Res       Date:  2012-08-27       Impact factor: 12.531

Review 9.  Sex differences in the expression of hepatic drug metabolizing enzymes.

Authors:  David J Waxman; Minita G Holloway
Journal:  Mol Pharmacol       Date:  2009-05-29       Impact factor: 4.436

10.  Retrospective Review of Clozapine Use in Children and Adolescents.

Authors:  Ardelle Komaryk; Dean Elbe; Leah Burgess
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2021-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.